| Cognitive Disengagement Syndrome in Functional Neurological Symptom Disorder (NCT07451821) | Elazığ Mental Health and Diseases Hospital | 2026-07-01 |
| Psychiatric Symptom Characteristics in Methamphetamine-Induced Psychosis With and Without Lifetime Cannabis Use (NCT07459270) | Elazığ Mental Health and Diseases Hospital | 2026-03-16 |
| LRFN5 and OLFM4 in Schizoaffective Disorder (NCT07447960) | Elazığ Mental Health and Diseases Hospital | 2026-03-02 |
| LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis (NCT07450027) | Elazığ Mental Health and Diseases Hospital | 2025-09-01 |
| IL-33, sST2, and CRP in Panic Disorder (NCT07444879) | Elazığ Mental Health and Diseases Hospital | 2025-07-07 |
| LRFN5 and OLFM4 in Bipolar Disorder (NCT07434414) | Elazığ Mental Health and Diseases Hospital | 2025-07-07 |
| α-N-acetylgalactosaminidase Levels in Panic Disorder (NCT07424911) | Elazığ Mental Health and Diseases Hospital | 2025-05-01 |
| α-N-acetylgalactosaminidase in Methamphetamine Psychosis (NCT07434401) | Elazığ Mental Health and Diseases Hospital | 2025-05-01 |
| LRFN5 and OLFM4 in Schizophrenia (NCT07434388) | Elazığ Mental Health and Diseases Hospital | 2025-04-27 |
| α-N-acetylgalactosaminidase in Schizoaffective Disorder (NCT07673718) | Elazığ Mental Health and Diseases Hospital | 2025-04-25 |
| ECG Findings in Methamphetamine Use (NCT07459244) | Elazığ Mental Health and Diseases Hospital | 2025-04-07 |
| Psychiatric Symptom Predictors in Methamphetamine-Induced Psychosis (NCT07459257) | Elazığ Mental Health and Diseases Hospital | 2025-02-03 |
| Type D Personality and Life Satisfaction in Bipolar Disorder Type 2 and Major Depressive Disorder (NCT07679204) | Elazığ Mental Health and Diseases Hospital | 2024-12-23 |